Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.
Luiten RM, Kueter EW, Mooi W, Gallee MP, Rankin EM, Gerritsen WR, Clift SM, Nooijen WJ, Weder P, van de Kasteele WF, Sein J, van den Berk PC, Nieweg OE, Berns AM, Spits H, de Gast GC. Luiten RM, et al. Among authors: berns am. J Clin Oncol. 2005 Dec 10;23(35):8978-91. doi: 10.1200/JCO.2005.01.6816. Epub 2005 Oct 31. J Clin Oncol. 2005. PMID: 16260696 Clinical Trial.
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.
Soiffer R, Lynch T, Mihm M, Jung K, Rhuda C, Schmollinger JC, Hodi FS, Liebster L, Lam P, Mentzer S, Singer S, Tanabe KK, Cosimi AB, Duda R, Sober A, Bhan A, Daley J, Neuberg D, Parry G, Rokovich J, Richards L, Drayer J, Berns A, Clift S, Cohen LK, Mulligan RC, Dranoff G. Soiffer R, et al. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13141-6. doi: 10.1073/pnas.95.22.13141. Proc Natl Acad Sci U S A. 1998. PMID: 9789055 Free PMC article. Clinical Trial.
A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.
Dranoff G, Soiffer R, Lynch T, Mihm M, Jung K, Kolesar K, Liebster L, Lam P, Duda R, Mentzer S, Singer S, Tanabe K, Johnson R, Sober A, Bhan A, Clift S, Cohen L, Parry G, Rokovich J, Richards L, Drayer J, Berns A, Mulligan RC. Dranoff G, et al. Hum Gene Ther. 1997 Jan 1;8(1):111-23. doi: 10.1089/hum.1997.8.1-111. Hum Gene Ther. 1997. PMID: 8990000 Clinical Trial. No abstract available.
Tumor microenvironment revisited.
Berns A, Pandolfi PP. Berns A, et al. EMBO Rep. 2014 May;15(5):458-9. doi: 10.1002/embr.201438794. Epub 2014 Apr 14. EMBO Rep. 2014. PMID: 24731944 Free PMC article. No abstract available.
Preclinical Models of Malignant Mesothelioma.
Testa JR, Berns A. Testa JR, et al. Front Oncol. 2020 Feb 11;10:101. doi: 10.3389/fonc.2020.00101. eCollection 2020. Front Oncol. 2020. PMID: 32117751 Free PMC article. Review.
Good news for gene therapy.
Berns A. Berns A. N Engl J Med. 2004 Apr 15;350(16):1679-80. doi: 10.1056/NEJMcibr040341. N Engl J Med. 2004. PMID: 15084702 No abstract available.
Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells.
Mezzapelle R, Rrapaj E, Gatti E, Ceriotti C, Marchis FD, Preti A, Spinelli AE, Perani L, Venturini M, Valtorta S, Moresco RM, Pecciarini L, Doglioni C, Frenquelli M, Crippa L, Recordati C, Scanziani E, de Vries H, Berns A, Frapolli R, Boldorini R, D'Incalci M, Bianchi ME, Crippa MP. Mezzapelle R, et al. Sci Rep. 2016 Mar 10;6:22850. doi: 10.1038/srep22850. Sci Rep. 2016. PMID: 26961782 Free PMC article.
Drugging drug resistance.
Dannenberg JH, Berns A. Dannenberg JH, et al. Cell. 2010 Apr 2;141(1):18-20. doi: 10.1016/j.cell.2010.03.020. Cell. 2010. PMID: 20371339 Free article.
We Are Standing on the Shoulders of Giants.
Berns A. Berns A. Cancer Res. 2016 Aug 1;76(15):4307-8. doi: 10.1158/0008-5472.CAN-16-1870. Cancer Res. 2016. PMID: 27480958 No abstract available.
11 results